Floatz logo

AMIDASE, SULFOGLUCOSAMINE SULF-

Mucopolysaccharidosis (MPS)

Shireprotein_peptidePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the Mucopolysaccharidosis (MPS) cohort.

Asset / SponsorPhaseRating
.BETA.-GLUCURONIDASE (SYNTHETIC HUMAN), HOMOTETRAMER
Ultragenyx Pharmaceutical Inc
Phase 3BBB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Takeda
Phase 4BB
gc1111
Takeda
Phase 4BB
METHOTREXATE
Takeda
Phase 4BB
HUMAN IMMUNOGLOBULINS
Takeda
Phase 4B

View all 13 →

Same molecule, other indications

AMIDASE, SULFOGLUCOSAMINE SULF- is also rated in:

mucopolysaccharidosis type 3Dormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →